staceywhite, Author at European Medical Journal - Page 44 of 195

Virtual Discovery of Immune-Stimulating Epitopes in Chikungunya Virus for Vaccine Design

Epitope identification is a key step in vaccine development, and this can be achieved much faster and less expensively with in silico…

The Future of Infection Treatment and Prevention in Immunocompromised Patients

THE emerging role of biological therapies in treating and preventing infection in patients who are immunocompromised was the primary focus…

Hand Washing Practices and Antibiotic Susceptibility of Palmar Bacterial Flora

Hand hygiene is one of the most effective and inexpensive means of preventing the spread of communicable diseases. Rates of handwashing…

Congress Interview: Johnny Zakhour

False positive results in infectious diseases greatly contribute to overtreatment and adverse events in patients. This is particularly important for blood cultures…

AMJ Neurology is out now!

AMJ’s inaugural neurology edition covers the latest new insights from the space – ranging from the intricacies of ageing and Alzheimer’s…

Review of the 76th American Academy of Neurology (AAN) Annual Meeting

DENVER, Colorado, USA, was the backdrop for the 2024 American Academy of Neurology (AAN) Annual Meeting. Coined as the Mile High City…

Interview: Yaakov Stern

When I was doing my BA in psychology, I found myself more interested in the research side of the subject; a lot of people who were…

Updated Study Data for Ozanimod in Relapsing Multiple Sclerosis

Presenting data from ENLIGHTEN and DAYBREAK, covering cognitive processing, brain volume, disability progression, rebound, and…

Ozanimod Long-Term Safety and Efficacy

S1P receptor 1 and 5 modulator for relapsing forms of MS in adults, including clinically isolated syndrome, relapsing-remitting disease…

New Frontiers in Alzheimer’s Disease

THIS YEAR’s American Academy of Neurology (AAN) Annual Meeting, held in Denver, Colorado, USA, from April 13–18, featured an insightful…